Northern Trust Corp Increases Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Northern Trust Corp raised its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 18.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 966,347 shares of the company's stock after purchasing an additional 147,522 shares during the quarter. Northern Trust Corp owned 1.13% of Pediatrix Medical Group worth $12,678,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. Nomura Asset Management Co. Ltd. increased its holdings in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after purchasing an additional 1,220 shares during the period. Parkside Financial Bank & Trust increased its holdings in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after purchasing an additional 1,040 shares during the period. AlphaQuest LLC increased its holdings in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after purchasing an additional 2,012 shares during the period. Smartleaf Asset Management LLC increased its holdings in shares of Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after purchasing an additional 6,090 shares during the period. Finally, Tower Research Capital LLC TRC increased its holdings in shares of Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after purchasing an additional 5,104 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Wall Street Zen raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Macquarie raised their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. UBS Group dropped their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a report on Monday, May 12th. Finally, Truist Financial dropped their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $16.67.

Pediatrix Medical Group Price Performance

MD stock traded down $1.20 during mid-day trading on Thursday, reaching $13.98. 1,280,598 shares of the company's stock were exchanged, compared to its average volume of 852,938. The company has a market cap of $1.20 billion, a price-to-earnings ratio of -11.65, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The stock's 50 day moving average is $13.78 and its 200 day moving average is $14.12. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. The company had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Pediatrix Medical Group's revenue for the quarter was down 7.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.20 earnings per share. On average, research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.